• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Natera Inc (NQ: NTRA )

    130.06 +4.31 (+3.43%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Oct 11, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 963,047
    Open 125.94
    Bid (Size) 130.03 (7)
    Ask (Size) 130.06 (1)
    Prev. Close 125.75
    Today's Range 125.84 - 131.54
    52wk Range 36.90 - 133.54
    Shares Outstanding 123,681,432
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Why the high growth investor may take a look at NATERA INC (NASDAQ:NTRA).
    Why the high growth investor may take a look at NATERA INC (NASDAQ:NTRA). 
    Via Chartmill
    A Biotech Breakout Will Be Led By Small Caps
    It’s hard to focus on biotech stocks right now because there are many distractions. The Fed and the rate cuts, AI and semiconductor stocks and geopolitical turmoil seemingly worse than ever. 
    Via Talk Markets
    Topics Artificial Intelligence Economy
    Exposures Artificial Intelligence Interest Rates

    Performance

    YTD
    +110.05%
    +110.05%
    1 Month
    +9.54%
    +9.54%
    3 Month
    +17.37%
    +17.37%
    6 Month
    +34.48%
    +34.48%
    1 Year
    +190.25%
    +190.25%

    More News

    Read More
    Court Orders Permanent Injunction Against NeoGenomics' Accused RaDaR Assay, as Case Enters New Phase
    From Natera, Inc.
    Via Business Wire
    Tempus AI Stock Clears Technical Benchmark, Hitting 80-Plus RS Rating
    Via Investor's Business Daily
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    Analyst Scoreboard: 9 Ratings For Natera
    Via Benzinga
    Peering Into Natera's Recent Short Interest
    Via Benzinga
    Peeling Back The Layers: Exploring Natera Through Analyst Insights
    Via Benzinga
    Forecasting The Future: 6 Analyst Projections For Natera
    Via Benzinga
    Natera Announces Three New Signatera Publications; Includes Groundbreaking Overall Survival Data Published in Nature Medicine and also Released at ESMO
    From Natera, Inc.
    Via Business Wire
    First of its Kind Colorectal Cancer Data from Prospective GALAXY Study Released at ESMO; Demonstrates Signatera's Ability to Predict Overall Survival
    From Natera, Inc.
    Via Business Wire
    Natera to Present New Signatera™ Colorectal Cancer Data at ESMO Showing 10X Advantage in Overall Survival
    From Natera, Inc.
    Via Business Wire
    $100 Invested In Natera 5 Years Ago Would Be Worth This Much Today
    Via Benzinga
    (NTRA) - Analyzing Natera's Short Interest
    Via Benzinga
    Here's How Much You Would Have Made Owning Natera Stock In The Last 5 Years
    Via Benzinga
    Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
    Via The Motley Fool
    Shopify, Palantir And Uber Are Among Top 10 Large Cap Gainers Last Week (Aug 4-Aug 10): Are The Others In Your Portfolio?
    Via Benzinga
    NTRA Stock Earnings: Natera Beats EPS, Beats Revenue for Q2 2024
    Via InvestorPlace
    Natera Reports Second Quarter 2024 Financial Results
    From Natera, Inc.
    Via Business Wire
    10 Health Care Stocks Whale Activity In Today's Session
    Via Benzinga
    $1000 Invested In This Stock 5 Years Ago Would Be Worth $4,300 Today
    Via Benzinga
    Natera to Participate in the Canaccord Genuity 44th Annual Growth Conference
    From Natera, Inc.
    Via Business Wire
    Natera to Report its Second Quarter 2024 Results on August 8, 2024
    From Natera, Inc.
    Via Business Wire
    New MultiCenter Prospective Study Demonstrates Signatera’s Clinical Utility in Merkel Cell Carcinoma
    From Natera, Inc.
    Via Business Wire
    The 3 Best Gene Editing Stocks to Buy in July 2024
    Via InvestorPlace
    Natera to Present at the 28th International Conference on Prenatal Diagnosis and Therapy
    From Natera, Inc.
    Via Business Wire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.